Community/Retail

The 2018 Accenture survey on technology and healthcare shows a steady increase in utilization by consumers for their health.

Instead of providing your patients with a short answer and directing them to the correct aisle, maybe next time you can also provide them with tips and things to avoid when struggling with IBS-D.

Direct-to-consumer genetic testing is becoming a hot field, and while 23andMe is making some good press, companies like Helix are putting some pressure for how to use that data.

ADA urges health care providers to continue to develop personalized care plans that can yield optimal short and long-term results for each individual with diabetes.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

Did you know that eyedrops are color-coded for patient safety and adherence?

Pharmacists are medication experts who play an integral role in the health care team. I am honored to be a pharmacist and believe that we are lifelong learners.

Novartis makes a move in the digital health field, and we may see more traction with pharmacological treatments and technological platforms.

Over the years, a number of landmark clinical studies on the management of AF have been published, sharping how patients are treated. Here are 4 that every pharmacist should know about.

Emergency department (ED) visits in the United States for opioid overdoses are up, signaling that the epidemic is worsening, according to a recent CDC report.

In oral testimony before the US House Committee on Energy and Commerce Subcommittee on Oversight and Investigations, FDA Commissioner Scott Gottlieb, MD, urged immediate steps that can be taken to enhance the product of existing licensed influenza vaccines.

These are some of the top foods that may seem 'healthy, but can sabotage your nutrition efforts.

Cigna Corporation and Express Scripts have announced an agreement in which Cigna will purchase the pharmacy benefit manager (PBM) for $67 billion, which includes $15 billion in Express Scripts debt.

In the first and second parts of 'Back to School,' we learned how pharmacy school has changed over the years. In Part 3, we talk to current PharmD student Eric Kinney.

Back by popular demand, we talk to more hardworking pharmacists with fascinating side hustles.

Medical schools are working to bring AR and VR technology into the classroom. Could pharmacy do the same?

Obesity has been considered a risk factor for severe acute respiratory illness, including more severe cases of the flu, but a recently-published study found that weight may not be associated with increased illness severity.

Pharmacists are exposed to increasing job stress. Why does that matter?

March is National Sleep Awareness Month, and pharmacists can help patients get their rest.

Many small health start-ups are leveraging digital health and telemedicine services to provide patient coaching. A new study from one company demonstrates that users could see as much as a 0.8% reduction in A1c.

The American College of Physicians (ACP) recently issued new guidelines aimed at assisting clinicians in making decisions about targets when using pharmacologic therapy in adults with type 2 diabetes.

Officials with the FDA have approved a supplemental new drug application (sNDA) to expand the use of lurasidone HCl (Latuda, Sunovion) to include the treatment of bipolar depression in pediatric patients (10 to 17 years of age).

The online retailing giant has its own brand of nonprescription drugs. Can it compete?

Talk to your patients about alternative therapy with these tips

The past decade has seen a large change in the field of pharmacy, with many companies changing the landscape with new mergers and acquisitions.

Looking to get their data into clinician hands, Higi has teamed up with Rush to get their data into institutions using Epic's EHRs.

More smart inhalers are coming to the US market and pharmacists may see them soon.

Officials with the FDA have approved ibalizumab-uiyk (Trogarzo, TaiMed Biologics), the first antiretroviral medication for adults with HIV who cannot be successfully treated with other therapies.